Aprea Therapeutics Strengthens Global Patent Portfolio In Dna Damage Response (Ddr) Cancer Therapeutics

Reuters
2026.02.12 14:02
Feb 12 (Reuters) - Aprea Therapeutics Inc (APRE.O) : * APREA THERAPEUTICS STRENGTHENS GLOBAL PATENT PORTFOLIO IN DNA DAMAGE RESPONSE (DDR) CANCER THERAPEUTICS, PAVING WAY FOR PIPELINE GROWTH * APREA THERAPEUTICS INC - GRANTED NEW PATENTS IN AUSTRALIA AND JAPAN * APREA THERAPEUTICS INC - CORE PATENT FAMILIES EXPECTED TO PROVIDE EXCLUSIVITY INTO 2045 * APREA THERAPEUTICS INC - EXISTING ISSUED PATENTS EXPECTED TO REMAIN IN FORCE THROUGH 2035-2037 Source text: Further company coverage: (APRE.O)
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer